GMCH faculty spar over principal, director posts

CHANDIGARH: Though the process for selection of director principal at Government Medical College and hospital (GMCH)-32 has started, first time there is a growing demand by the faculty for segregation of this post. On the pattern of Punjab, GMCH faculty are demanding separate posts for principal and director.

Recently a new faculty association has been formed that has placed a demand for the same. Sources inform that the faculty had reasoned that as Punjab recruitment rules are followed by the medical college, segregation of the post must be applicable too. However there are others who contest. “We have only one medical college in the city unlike Punjab. So how can we have a separate post ?” said a faculty member.

However, officiating director-principal Dr BS Chavan expressed his unawareness about any such demand by the faculty. “I have not received any such communication till now on this.”

The demand by the faculty is based on offering opportunity to senior doctors to apply for two posts. “The director cannot give time for the college and also carry on with administrative work. This reason is that there are separate posts in Punjab. Similarly, with the enhancement of MBBS seats and postgraduation seats, burden on principal increases,” said a senior faculty.

  • Related Posts

    Yashoda Medicity’s Medical Tourism Footprint widens with Republic of Kazakhstan on Board

    MOU signed for Patient Referrals, Tele-Consultations and Specialist Healthcare Collaboration Delhi NCR: Unveiled not long ago, Yashoda Medcity’s reputation as being best in class healthcare facility in Delhi NCR has…

    Liver enters FATal Straits in India, AIIMS Experts red flag

    In first for India, World Congress of Gastroenterology comes calling to asses GI disease burden New Delhi: As global and national burden of digestive diseases reach a critical crossroads, World…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre